Genetic polymorphisms in venous thrombosis and pulmonary embolism after total hip arthroplasty: A pilot study

Clinical Orthopaedics and Related Research

Volumn 467, Issue 6, 2009, Pages 1507-1515

  Ringwald, Juergen ^a   Berger, Annika ^b   Adler, Werner ^c   Kraus, Cornelia ^a   Pitto, Rocco P ^d  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b HARVARD UNIVERSITY   (United States)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; PLASMINOGEN ACTIVATOR INHIBITOR; PROTHROMBIN; BLOOD CLOTTING FACTOR 5; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LUNG EMBOLISM; MALE; PILOT STUDY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOPHILIA; TOTAL HIP PROSTHESIS; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HIP ARTHROPLASTY; MULTICENTER STUDY; MUTATION; NONPARAMETRIC TEST; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; RISK; VEIN THROMBOSIS;

AGED; ARTHROPLASTY, REPLACEMENT, HIP; CHI-SQUARE DISTRIBUTION; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; ODDS RATIO; PILOT PROJECTS; PLASMINOGEN INACTIVATORS; POLYMORPHISM, GENETIC; POSTOPERATIVE COMPLICATIONS; PROTHROMBIN; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; VENOUS THROMBOSIS;

EID: 66349135044     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-008-0498-7     Document Type: Article

References (44)

1. N Akar E Akar R Akcay F Avcu A Yalcin S Cin 2000 Effect of methylenetetrahydrofolate reductase 677 C-T, 1298 A-C, and 1317 T-C on factor V 1691 mutation in Turkish deep vein thrombosis patients Thromb Res 97 163 167 10680647 10.1016/S0049-3848(99)00157-7 1:CAS:528:DC%2BD3cXhtlCitro%3D (Pubitemid 30055281)
2. N Akar E Yilmaz E Akar F Avcu A Yalcin S Cin 2000 Effect of plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish deep vein thrombotic patients with and without FV1691 G-A Thromb Res 97 227 230 10674409 10.1016/S0049-3848(99)00164-4 1:CAS:528:DC%2BD3cXosVWmsw%3D%3D (Pubitemid 30069711)
3. WY Alamawi H Tamim R Kreidy G Timson E Rahal M Nabulsi RR Finan N Irani-Hakime 2005 A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis J Thromb Thrombolysis 19 189 196 10.1007/s11239-005-1313- x (Pubitemid 41149481)
4. CF Allaart SR Poort FR Rosendaal PH Reitsma RM Bertina E Briet 1993 Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect Lancet 341 134 138 8093743 10.1016/0140-6736(93)90003-Y 1:STN:280:DyaK3s7ktVCgtw%3D%3D (Pubitemid 23029305)
5. M Baba-Ahmed G Le Gal F Couturaud K Lacut E Oger C Leroyer 2007 High frequency of factor V Leiden in surgical patients with symptomatic venous thromboembolism despite prophylaxis Thromb Haemost 97 171 175 17264942 1:CAS:528:DC%2BD2sXkt1eqtbc%3D
6. B Beksac A Gonezález Della Valle EA Salvati 2006 Thromboembolic disease after total hip arthroplasty: who is at risk? Clin Orthop Relat Res 453 211 224 17006373 10.1097/01.blo.0000238848.41670.41 (Pubitemid 44900986)
7. G Böhm H Al-Khaffa 2003 Thrombophilia and arterial diseases: an up-to-date review of the literature for the vascular surgeon Int Angiol 22 116 124 12865876
8. M Campos S Morais JM Cabeda B Justica 2000 Absence of venous thromboembolism during orthopaedic surgery in patients with FV Leiden mutation or 20210 A allele of prothrombin gene Haemostasis 30 suppl 1 35
9. B Dahlback 1994 Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene Haemostasis 24 139 7959362 1:STN:280:DyaK2M%2FkslylsQ%3D%3D
10. TB Domagala L Adamek E Nizankowska M Sanak A Szczeklik 2002 Mutations C677T and A1298C of the 5, 10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease Blood Coagul Fibrinolysis 13 423 431 12138370 10.1097/00001721-200207000-00007 1:CAS:528:DC%2BD38Xmslakurk%3D (Pubitemid 35001859)
11. RF Franco V Morelli D Lourenco FH Maffei MH Tavella CE Piccinato IA Thomazini MA Zago 1999 A second mutation in the methylenetetrahydrofolate reductase gene and the risk of venous thrombotic disease Br J Haematol 105 556 559 10233437 10.1111/j.1365-2141.1999.01254.x 1:CAS:528:DyaK1MXjslWjsLY%3D
12. RF Franco PH Reitsma 2001 Genetic risk factors of venous thrombosis Hum Genet 109 369 384 11702218 10.1007/s004390100593 1:CAS:528:DC%2BD3MXnvFeitb0%3D (Pubitemid 33064516)
13. P Frosst HJ Blom R Milos P Goyette CA Sheppard RG Matthews GJ Boers M den Heijer LA Kluijtmans LP van den Heuvel R Rozen 1995 A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase Nat Genet 10 111 113 7647779 10.1038/ng0595-111 1:CAS:528: DyaK2MXlsVymt78%3D
14. German Institute for Medical Documentation and Information. The International Classification of Diseases, Tenth Revision (ICD-10), German modification, 2008. Available at: www.dimdi.de/static/de/klassi/diagnosen/icd10/ htmlgm2008/fr-icd.htm. Accessed January 2008.
15. SB Haas CB Tribus JN Insall MW Becker RE Windsor 1992 The significance of calf thrombi after total knee arthroplasty J Bone Joint Surg Br 74 799 802 1447236 1:STN:280:DyaK3s%2FnslKjug%3D%3D
16. NQ Hanson O Aras F Yang MY Tsai 2001 C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease Clin Chem 47 661 666 11274015 1:CAS:528:DC%2BD3MXis1KjurY%3D
17. TF Imperiale T Speroff 1994 A meta-analysis of methods to prevent venous thromboembolism following total hip replacement JAMA 271 1780 1785 7515115 10.1001/jama.271.22.1780 1:STN:280:DyaK2c3lsVWksQ%3D%3D (Pubitemid 24166618)
18. JE Joseph J Low B Courtenay MJ Neil M McGrath D Ma 2005 A single-centre prospective study of clinical and haemostatic risk factors for venous thromboembolism following lower limb arthroplasty Br J Haematol 129 87 92 15801960 10.1111/j.1365-2141.2005.05419.x (Pubitemid 40524056)
19. PJ Kelly J Rosand J Kistler VE Shih S Silveira A Plomaritoglou KL Furie 2002 Homocysteine, MTHFR 677C->T polymorphism, and risk of ischemic stroke: results of a meta-analysis Neurology 59 529 536 12196644 1:CAS:528:DC%2BD38XntlSrsbY%3D
20. TL Lindahl TH Lundahl L Nilsson CA Andersson 1999 APC-resistance is a risk factor for postoperative thromboembolism in elective replacement of the hip or knee: a prospective study Thromb Haemost 81 18 21 10348713 1:CAS:528:DyaK1MXhvVaqt7s%3D
21. GD Lowe F Haverkate G Thompson RM Turner RM Bertina AG Turpie PM Mannucci The ECAT DVT Study Group 1999 Prediction of deep vein thrombosis after elective hip replacement surgery by preoperative clinical and haemostatic variables: The ECAT DVT Study Thromb Haemost 81 879 886 10404761 1:CAS:528:DyaK1MXjvFahtr4%3D
22. S Naushad NJ Jamal R Angalena CK Prasad AR Devi 2007 Hyperhomocysteinemia and the compound heterozygous state for methylene tetrahydrofolate reductase are independent risk factors for deep vein thrombosis among South Indians Blood Coagul Fibrinolysis 18 113 117 17287626 10.1097/MBC.0b013e3280108e01 1:CAS:528:DC%2BD2sXhsVSisLc%3D (Pubitemid 46232830)
23. CS Philipp A Dilley P Saidi B Evatt H Austin J Zawadsky D Harwood D Ellingsen E Barnhart DJ Philips WC Hooper 1998 Deletion polymorphism in the angiotensin-converting enzyme gene as a thrombophilic risk factor after hip arthroplasty Thromb Haemost 80 869 873 9869151 1:CAS:528:DyaK1cXotVSmu7Y%3D
24. SR Poort FR Rosendaal PH Reitsma RM Bertina 1996 A common genetic variation in the 3-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis Blood 88 3698 3703 8916933 1:CAS:528:DyaK28XntVahsLg%3D
25. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2008. Available at: www.R-project.org. Accessed January 2008.
26. JG Ray 1998 Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease Arch Intern Med 158 2101 2106 9801176 10.1001/archinte.158.19.2101 1:STN:280:DyaK1M%2FhsFOqtw%3D%3D (Pubitemid 28482092)
27. DC Rees M Cox JB Clegg 1995 World distribution of factor V Leiden Lancet 346 1133 1134 7475606 10.1016/S0140-6736(95)91803-5 1:STN:280: DyaK28%2Fjs1Chuw%3D%3D
28. FR Rosendaal CJM Doggen A Zivelin VR Arruda M Aiach DS Siscovick A Hillarp HH Watzke F Bernardi AM Cumming FE Preston PH Reitsma 1998 Geographic distribution of the 20210G to A prothrombin variant Thromb Haemost 79 706 708 9569177 1:CAS:528:DyaK1cXit12nsrc%3D
29. DH Ryan MA Crowther JS Ginsberg CW Francis 1998 Relation of factor V Leiden genotype to risk for acute deep venous thrombosis after joint replacement surgery Ann Intern Med 128 270 276 9471929 1:STN:280:DyaK1c7itFOrtA%3D%3D
30. O Salomon N Rosenberg A Zivelin DM Steinberg N Kornbrot R Dardik A Inbal U Seligsohn 2001 Methionine synthase A2756G and methylenetetrahydrofolate reductase A1298C polymorphisms are not risk factors for idiopathic venous thromboembolism Hematol J 2 38 41 11920232 10.1038/sj.thj.6200078 1:CAS:528:DC%2BD3MXnvFOksbc%3D (Pubitemid 32266384)
31. EA Salvati AG Della Valle GH Westrich AJ Rana L Specht BB Weksler P Wang CJ Glueck 2005 The John Charnley Award: heritable thrombophilia and development of thromboembolic disease after total hip arthroplasty Clin Orthop Relat Res 441 40 55 16330983 10.1097/01.blo.0000192366.61616.81 (Pubitemid 44384202)
32. MT Sartori C Danesin G Saggiorato D Tormene P Simioni L Spiezia 2003 The PAI-1 gene 4G/5G polymorphism and deep vein thrombosis in patients with inherited thrombophilia Clin Appl Thromb Hemost 9 299 307 14653439 10.1177/107602960300900405 1:CAS:528:DC%2BD3sXpvVOqtbo%3D
33. AE Sass EJ Neufeld 2002 Risk factors for thromboembolism in teens: when should I test? Curr Opin Pediatr 14 370 378 12130896 10.1097/00008480-200208000- 00002 (Pubitemid 34774918)
34. R Segui A Estelles Y Miar F Espana P Villa C Falco A Vaya S Grancha F Ferrando J Aznar 2000 PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects Br J Haematol 111 122 128 11091191 10.1046/j.1365-2141.2000.02321.x 1:CAS:528:DC%2BD3cXosFSgu7s%3D (Pubitemid 30832441)
35. RE Simmonds H Ireland DA Lande B Zöller P Garcia de Frutos B Dahlbäck 1998 Clarification of the risk for venous thrombosis associated with hereditary protein S deficiency by investigation of a large kindred with a characterized gene defect Ann Intern Med 128 8 14 9424998 1:STN:280: DyaK1c%2FmvFKitg%3D%3D
36. PJ Svensson G Benoni H Fredin O Björgell P Nilsson U Hedlund G Nylander D Bergqvist B Dahlbaeck 1997 Female gender and resistance to activated protein C (FV:Q506) as potential risk factors for thrombosis after elective hip arthroplasty Thromb Haemost 78 993 996 9308742 1:CAS:528:DyaK2sXmtVejsrY%3D
37. AE Tsantes GK Nikolopoulos PG Bagos E Rapti G Mantzios V Kapsimali A Travlou 2007 Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and venous thrombosis: a meta-analysis Thromb Haemost 97 907 913 17549286 1:CAS:528:DC%2BD2sXmvVWkurk%3D (Pubitemid 46939203)
38. PT Vaitkus A Leizorovicz AT Cohen AG Turpie CG Olsson SZ Goldhaber PREVENT Medical Thromboprophylaxis Study Group 2005 Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients Thromb Haemost 93 76 79 15630494 1:CAS:528:DC%2BD2MXptVyntQ%3D%3D
39. NM van der Put F Gabreëls EM Stevens JA Smeitink FJ Trijbels TK Eskes LP van den Heuvel HJ Blom 1998 A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62 1044 1051 9545395 10.1086/301825 (Pubitemid 28199004)
40. K Wahlander G Larson TL Lindahl C Andersson L Frison D Gustaffsson A Bylock BI Eriksson 2002 Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery Thromb Haemost 87 580 585 12008938 1:CAS:528:DC%2BD38Xjt1egt7s%3D
41. GH Westrich BB Weksler CJ Glueck BF Blumenthal EA Salvati 2002 Correlation of thrombophilia and hypofibrinolysis with pulmonary embolism following total hip arthroplasty J Bone Joint Surg Am 84 2161 2167 12473703
42. ST Woolson JL Zehnder WJ Maloney 1998 Factor V Leiden and the risk of proximal venous thrombosis after total hip arthroplasty J Arthroplasty 13 207 210 9526216 10.1016/S0883-5403(98)90101-2 1:STN:280:DyaK1c7os12ltg%3D%3D (Pubitemid 28106825)
43. Wu O, Robertson L, Twaddle S, Lowe GD, Clark P, Greaves M, Walker ID, Langhorne P, Brenkel I, Regan L, Greer I. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technol Assess. 2006;10:1-110.
44. H Zetterberg A Coppola A D'Angelo M Palmér L Rymo K Blennow 2002 No association between the MTHFR A1298C and transcobalamin C776G genetic polymorphisms and hyperhomocysteinemia in thrombotic disease Thromb Res 108 127 131 12590948 10.1016/S0049-3848(03)00004-5 1:CAS:528:DC%2BD3sXht1Cqsrc%3D (Pubitemid 36184648)